COMPLIS

BioCryst Pharmaceuticals, Inc.

Application Filed: 2011-10-07

Trademark Application Details

Status

606

Dead/Abandoned

ABANDONED - NO STATEMENT OF USE FILED

Research	OneLook Acronym Finder
Serial Number	85442018
Mark Drawing Code	4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form
Attorney Name	Thomas G. Peterson
Attorney Docket Number	T78891US14GP
Law Office Assigned	L50
Employee Name	HUSSAIN, TASNEEM

Timeline

2011-10-07	Application Filed
2012-03-20	Published for Opposition
2012-05-15	Location: INTENT TO USE SECTION
2012-12-17	Abandon
2012-12-17	Status: Dead/Abandoned
2018-07-08	Transaction Date

Trademark Applicants & Owners

Owner:	BioCryst Pharmaceuticals, Inc.
Address	4505 Emperor Blvd, Ste 200 Durham DE 27703
Legal Entity Type	Corporation
Legal Entity State	DE

Documents

Click the blue "Refresh" button to load certificates, specimines, application, and other documents.

Attorney of Record

THOMAS G. PETERSON
BRADLEY ARANT BOULT CUMMINGS, LLP
1819 5TH AVE N
BIRMINGHAM, AL 35203-2120

Good, Services, and Codes

International Codes:	5
U.S. Codes:	006,018,044,046,051,052

Type Code	Type
GS0051	Pharmaceuticals for the treatment of hepatitis, Acquired Immune Deficiency Syndrome (AIDS), SARS, and West Nile virus; pharmaceuticals for the treatment of inflammatory bowel diseases, inflammatory connective tissue diseases and inflammatory skin diseases; pharmaceuticals for the treatment of autoimmune, cancer and cardiovascular diseases and disorders; pharmaceuticals for the treatment of obesity; pharmaceuticals for the treatment of influenza; and anti-infective pharmaceuticals; pharmaceuticals for the treatment of viral and inflammatory diseases, infections and disorders

Type Code

Type

GS0051

Pharmaceuticals for the treatment of hepatitis, Acquired Immune Deficiency Syndrome (AIDS), SARS, and West Nile virus; pharmaceuticals for the treatment of inflammatory bowel diseases, inflammatory connective tissue diseases and inflammatory skin diseases; pharmaceuticals for the treatment of autoimmune, cancer and cardiovascular diseases and disorders; pharmaceuticals for the treatment of obesity; pharmaceuticals for the treatment of influenza; and anti-infective pharmaceuticals; pharmaceuticals for the treatment of viral and inflammatory diseases, infections and disorders

Trademark Filing History

Description	Date	Event Coding
NEW APPLICATION ENTERED IN TRAM	2011-10-11	1 NWAP I:Incoming Correspondence
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM	2011-10-14	2 NWOS I:Incoming Correspondence
ASSIGNED TO EXAMINER	2012-01-26	3 DOCK D:Assigned to Examiner
APPROVED FOR PUB - PRINCIPAL REGISTER	2012-01-26	4 CNSA P:
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED	2012-02-29	5 NONP E:E-Mail
PUBLISHED FOR OPPOSITION	2012-03-20	6 PUBO A:Allowance for Publication
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED	2012-03-20	7 NPUB E:E-Mail
NOA E-MAILED - SOU REQUIRED FROM APPLICANT	2012-05-15	8 NOAM E:E-Mail
ABANDONMENT - NO USE STATEMENT FILED	2012-12-17	9 ABN6 S:
ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED	2012-12-17	10 MAB6 O:Outgoing Correspondence

Similar Marks

Mark Image Registration \| Serial	Company Trademark Application Date
COMPLIS 85442018 not registered Dead/Abandoned	BioCryst Pharmaceuticals, Inc. 2011-10-07
COMPLIS 85294928 not registered Dead/Abandoned	Miralis inc. 2011-04-14
COMPLIS 78379687 not registered Dead/Abandoned	BioCryst Pharmaceuticals, Inc. 2004-03-05
COMPLIS 77429781 not registered Dead/Abandoned	BioCryst Pharmaceuticals, Inc. 2008-03-24
COMPLIS 75933711 not registered Dead/Abandoned	BioCryst Pharmaceuticals, Inc. 2000-03-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.